HLK R029
Alternative Names: HLK-R029Latest Information Update: 12 Jul 2024
At a glance
- Originator HLK Pharmacin
- Class Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Skin disorders
Most Recent Events
- 02 May 2024 Early research in Skin disorders in USA (HLK Pharmacin pipeline, April 2024)